ALOX5 and atherosclerosis: Another hypothesis is that the inhibition of COX enzymes by NSAIDs could redirect arachidonic acid (AA) to alternative enzymatic pathways, like 5-lipoxygenase (5-LOX) and leukotrienes (LTs), which play roles in atherosclerosis and inflammation processes.